A carregar...

Gemcitabine sensitivity factors, hENT1 and RRM1 as potential prognostic biomarker for advanced biliary tract cancer

Background and aims: Biliary tract caner (BTC) is one of rare malignant disease with poor prognosis. Gemcitabine has been widely used as chemotherapeutic agent for advanced BTC treatment. Several molecules involved in gemcitabine metabolism, including human equilibrative nucleoside transporter (hENT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Clin Exp Med
Main Authors: Deng, Ting, Pan, Hong, Han, Rubing, Huang, Dingzhi, Li, Hongli, Zhou, Likun, Wang, Xia, Bai, Ming, Li, Xiang, Liu, Rui, Ge, Shaohua, Ning, Tao, Zhang, Le, Ba, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307450/
https://ncbi.nlm.nih.gov/pubmed/25664003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!